PHARMACIELO LTD (PCLO.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:PCLO - CA71716K1012 - Common Stock
PCLO.CA Key Statistics, Chart & Performance
The current stock price of PCLO.CA is 0.095 CAD. In the past month the price increased by 72.73%. In the past year, price decreased by -32.14%.
PCLO.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is one of the better performing stocks in the market, outperforming 71.7% of all stocks.
PCLO.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PCLO.CA. Both the profitability and financial health of PCLO.CA have multiple concerns.
PCLO.CA Financial Highlights
Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 57.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.31% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PCLO.CA Forecast & Estimates
PCLO.CA Ownership
PCLO.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.9 | 3.75B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.57B | ||
| CRON.CA | CRONOS GROUP INC | 23.93 | 1.37B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.04 | 872.94M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.12 | 634.32M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 626.38M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 592.76M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 554.64M | ||
| TSND.CA | TERRASCEND CORP | N/A | 412.44M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.89 | 394.25M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 332.26M | ||
| HITI.CA | HIGH TIDE INC | N/A | 307.12M |
Related stock screener links
About PCLO.CA
Company Profile
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
Company Info
PHARMACIELO LTD
82 Richmond Street East
TORONTO ONTARIO M5C 2V6 CA
CEO: David Attard
Employees: 0
Phone: 14163158741.0
PHARMACIELO LTD / PCLO.CA FAQ
What does PHARMACIELO LTD do?
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
Can you provide the latest stock price for PHARMACIELO LTD?
The current stock price of PCLO.CA is 0.095 CAD.
Does PHARMACIELO LTD pay dividends?
PCLO.CA does not pay a dividend.
What is the ChartMill rating of PHARMACIELO LTD stock?
PCLO.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of PCLO stock?
PHARMACIELO LTD (PCLO.CA) operates in the Health Care sector and the Pharmaceuticals industry.
How is the valuation of PHARMACIELO LTD (PCLO.CA) based on its PE ratio?
PHARMACIELO LTD (PCLO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
Can you provide the market cap for PHARMACIELO LTD?
PHARMACIELO LTD (PCLO.CA) has a market capitalization of 17.85M CAD. This makes PCLO.CA a Nano Cap stock.